TrialThe oncologist2018
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance).
Jesus Vera Aguilera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
TrialThe oncologist2018
Jesus Vera Aguilera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.